Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 22 (1) , 58-66.e3
Abstract
No abstract availableKeywords
Funding Information
- Eli Lilly and Company
- Takeda Pharmaceutical Company
- AstraZeneca
- Merck Sharp and Dohme United Kingdom
- GlaxoSmithKline
- Incyte
- Merck
- Bristol-Myers Squibb
- Gilead Sciences
- Boehringer Ingelheim
- Amgen
- National Institutes of Health (T32CA009679)
- Novartis
This publication has 21 references indexed in Scilit:
- Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?Frontiers in Medicine, 2019
- Outcomes with pembrolizumab (pembro) monotherapy in patients (pts) with PD-L1–positive NSCLC with brain metastases: Pooled analysis of KEYNOTE-001, -010, -024, and -042Annals of Oncology, 2019
- Immunotherapy and radiotherapy for metastatic cancersAnnals of Palliative Medicine, 2019
- Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2018
- Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non–Small Cell Lung CancerJournal of Thoracic Oncology, 2018
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung CancerNew England Journal of Medicine, 2018
- Safety and efficacy analyses of atezolizumab in advanced non-small cell lung cancer (NSCLC) patients with or without baseline brain metastasesAnnals of Oncology, 2017
- The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancerCancer Treatment Reviews, 2016
- Management and Prognosis in Synchronous Solitary Resected Brain Metastasis from Non–Small-Cell Lung CancerClinical Lung Cancer, 2009
- Pronostic factors of synchronous brain metastases from lung cancerLung Cancer, 2001